# Cipla Limited · 66-66 · INDIA — FDA import alert red lists: firms subject to detention without physical examination

For Cipla Limited · 66-66 · INDIA, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is INDIA; product is Mebendazole; product code is 60 W - - 16 Mebendazole (Anthelmintic); date published is 10/09/2013; address is Patalganga Industrial Area , Plot No A-2, A-33, A-37/2/2, A-42 , Raigad, Maharashtra INDIA, verified against its source on 2026-09-16.

- **Firm:** Cipla Limited _(verified: appears in the quote below)_
- **Import alert:** 66-66
- **Import alert name:** "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- **Country:** INDIA _(verified: appears in the quote below)_
- **Address:** Patalganga Industrial Area , Plot No A-2, A-33, A-37/2/2, A-42 , Raigad, Maharashtra INDIA _(verified: appears in the quote below)_
- **Date published:** 10/09/2013 _(verified: appears in the quote below)_
- **Product code:** 60 W - - 16 Mebendazole (Anthelmintic) _(verified: appears in the quote below)_
- **Product:** Mebendazole _(verified: appears in the quote below)_

## What the source says

> Cipla Limited Date Published : 10/09/2013 Patalganga Industrial Area , Plot No A-2, A-33, A-37/2/2, A-42 , Raigad, Maharashtra INDIA 60 W - - 16 Mebendazole (Anthelmintic) Date Published: 10/09/2013 Desc: Mebendazole

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_202.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).